Intimation Regarding Reconstitution of Committees of the Board of Directors.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
The Board of Directors of Welcure Drugs & Pharmaceuticals has reconstituted three key committees — Audit Committee, Nomination and Remuneration Committee, and Stakeholders Relationship Committee — effective from August 5, 2025. All three committees have the same three independent directors: Mr. Ravi Thakor, Mr. Yogeshkumar Prajapati, and Mrs. Bhumika Pradhan, all classified as Non-Executive Independent Directors. Mr. Yogeshkumar Prajapati has been appointed as the Chairperson of all three committees, while Mr. Ravi Thakor and Mrs. Bhumika Pradhan serve as members. The intimation has been filed with BSE under Regulation 30 of SEBI LODR Regulations.
This is a routine corporate governance restructuring with no change in key managerial personnel. The Managing Director & CFO continues in his role. Shareholders are unlikely to see any material impact on stock price or operations from this filing.